Deborah Coupland
Family · Lakewood Ranch, FLNPI 1518204411
Payments from drug & device makers
Across 135 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$474
- Novo Nordisk$473
- AbbVie$349
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$331
- Amgen$241
- Currax Pharmaceuticals LLC$193
- plus $988 from 23 others
What the payments were for
- Food & beverage$2,77991%
- Education$2709%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $474 |
| Novo Nordisk | 19 | $473 |
| AbbVie | 12 | $349 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $331 |
| Amgen(2 entities) | 11 | $241 |
| Currax Pharmaceuticals LLC | 13 | $193 |
| Lilly USA, LLC | 8 | $125 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| Biohaven Pharmaceuticals, Inc. | 5 | $90 |
| Bayer | 2 | $81 |
| Nestle Healthcare Nutrition Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Johnson & Johnson | 2 | $54 |
| Pfizer | 3 | $54 |
| GSK | 3 | $41 |
| AstraZeneca | 3 | $41 |
| Radius Health, Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Exact Sciences | 1 | $21 |
| GRT US Holding, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Avion Pharmaceuticals | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Convatec Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,049 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 18 | $24,814 |
| FarxigaDapagliflozin Propanediol | 19 | $21,110 |
| MounjaroTirzepatide | 15 | $14,820 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,456 |
| TirosintLevothyroxine Sodium | 13 | $2,039 |
| Rosuvastatin Calcium | 59 | $822 |
| ProgesteroneProgesterone, Micronized | 16 | $464 |
| Escitalopram Oxalate | 26 | $453 |
| Levothyroxine Sodium | 60 | $439 |
| Liothyronine Sodium | 16 | $371 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $329 |
| Losartan Potassium | 30 | $319 |
| Amlodipine Besylate | 33 | $294 |
| Fluticasone Propionate | 27 | $244 |
| ValacyclovirValacyclovir Hcl | 16 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $41 | $21,11019 claims |
| Lilly USA, LLCMounjaro | $125 | $14,82015 claims |
| GSKTrelegy Ellipta | $41 | $7,45611 claims |
| IBSA Pharma Inc.Tirosint | $35 | $2,03913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Lakewood Ranch
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.